Driving flu vaccine uptake in the post-pandemic era

In this week's episode of "The Top Line," we look at factors driving the continuing decline of flu vaccination rates in the U.S. and beyond.

Fierce Pharma’s Zoey Becker chats with Gregg Sylvester, M.D., Chief Health Officer at CSL Seqirus, to get insight on what we might expect to see from this upcoming flu season. He also explains efforts to increase vaccine uptake through awareness and education campaigns.

To learn more about the topics in this episode:

Flu vaccine makers CSL Seqirus, Sanofi and GSK kick off initial shipments ahead of upcoming season
CDC starts 'Wild to Mild' campaign to reverse falling flu vaccine use in key groups
American Lung Association, Sanofi urge high-risk communities to grab their flu shots in 'United Against Flu' campaign

Driving flu vaccine uptake in the post-pandemic era

To learn more about the topics in this episode:

To Listen to More Episodes from The Top Line